Michael Kavanagh BSc MBA (Advanced)

CEO & President

Mr Michael Kavanagh joined Nanosonics as CEO & President effective 21st October 2013. Michael is a highly experienced executive with over 20 years of international commercial experience in the healthcare market having held local, regional and global roles in Medical Devices and Pharmaceutical industries. He holds a BSc Degree from University College Dublin and an MBA (Advanced) from the University of Queensland. Before joining Nanosonics, Michael was Senior Vice President of Global Marketing for the major medical device company Cochlear Limited, a position he held for more than 10 years

Ron Weinberger BSc (Hons), PhD

President Technology Development/Commercialisation

Dr Weinberger joined the Company in August 2004 and was appointed as Executive Director in July 2008. Dr Weinberger was appointed as Chief Executive Officer in May 2011. Dr Weinberger has executive responsibility for the overall leadership of the business and the implementation of its strategies. Since 2004 Dr Weinberger has been in a range of roles leading product development and overseeing manufacturing and operations. He is an intellectual property expert and entrepreneur in the development of novel technologies. Dr Weinberger is co-inventor of several of Nanosonics’ key technology patents which underpin the Company’s platform technology.

Steven Farrugia BE PhD

Senior Vice President, Design and Development

Dr Steven Farrugia joined Nanosonics as Senior Vice President, Design and Development, in September 2016. Steven has over 20 years' experience leading the development of medical devices, from initial concept, through to full commercialization. Prior to joining Nanosonics, Steven held a range of senior executive roles with medical device manufacturer ResMed, including VP of Technology and VP of Product Development. Steven is an inventor of close to 300 granted and pending patents and is an Adjunct Professor of Engineering at The University of Sydney.

McGregor Grant BEc, CA, GAICD

Chief Financial Officer and Company Secretary

Mr Grant joined Nanosonics in April 2011 and is responsible for the overall financial management of the Company and, together with Dr Weinberger, has joint responsibility for investor relations. Mr Grant has over 15 years of business experience in a number of senior roles in the medical device and healthcare industries located in Australia and the United States. Previously Mr Grant worked for Coopers & Lybrand in Australia and Europe.

Anthony Harrington BSc, MBA, GAICD

Senior Vice President, Global Marketing

Anthony Harrington joined Nanosonics in April 2017. He has more than 25 years’ experience in senior marketing and business development roles in the healthcare sector, with particular emphasis on the successful commercialisation (including D&D to realisation) of high tech medical devices in Australia, the UK, Europe and New Zealand. This includes seven years at Zimmer in senior regional product marketing management roles.

Anthony has also held executive and non-executive directorship roles, including Managing Director of Biomet ANZ (orthopaedics) and Vice Chairman of the Medical Technology Association of Australia (MTAA).

Gerard Putt BSc

Chief Operations Officer

Mr Putt joined Nanosonics full time in April 2011 after 18 months on the Nanosonics advisory board. Mr Putt has over 12 years’ experience in the Medical Device industry as a leader of development, engineering and production teams at ResMed. As Head of Manufacturing at ResMed, Mr Putt acquired particular experience in the implementation of new products into manufacturing and rapid scaling of production to international market needs. Mr Putt has a strong background in medical device GMP, project management, engineering and entrepreneurial roles in medical, retail and building.

Vincent Wang BSc, MSc, MBA

Head of Global Support and Services

Mr Wang has over 11 years’ experience in establishing and managing technical support and service repair function in global medical device markets. Before joining Nanosonics in May 2011, Mr Wang worked for Sonova Hearing Healthcare Group as Regional Service Operations Manager and at Cochlear as Regional Technical Service and Repair Manager.

Ruth Cremin MSc

Head of Quality and Regulatory Affairs

Ms Cremin joined Nanosonics in June 2011 and has extensive regulatory affairs experience, having worked at Cochlear for over 4 years as a Senior Regulatory Affairs Specialist for the ANZ and Asia Pacific Regions. Prior to this role, Ms Cremin worked at Pfizer Australia as a QA & Regulatory Officer for 4 years and was also a Regulatory Affairs Associate with Bio-Medical Research Ltd in Galway, Ireland.

Kirste Courtney BA

Human Resources Manager

Ms Courtney joined Nanosonics in 2009 and has over 14 years of human resources experience having worked in a variety of industry sectors including chartered accounting, media, logistics and banking.

Ronald J Bacskai BSME, MBA (Hons)

President & CEO, Nanosonics, Inc.

Mr Bacskai joined Nanosonics, Inc. in 2010 and is responsible for supporting Nanosonics, Inc. operations in the United States. Mr Bacskai is an experienced executive having worked in multiple industries with a broad technical, marketing and sales, and technology commercialization background. Mr Bacskai has significant experience as President, CEO and board member of several public and private organizations as well as serving on the advisory board of a speciality environmental firm.

Robert J Waring B.Ec (Syd), A.C.A., F.C.I.S., A.S.I.A., F.A.I.C.D.

Joint Company Secretary

Mr Waring was first appointed as Company Secretary in October 2005 and held this position at the time of the Company’s IPO in May 2007. He has over 40 years of experience in financial and corporate roles, including over 25 years in Company Secretarial roles for ASX-listed companies, and over 20 years as a Director of ASX-listed companies. He is a director of Oakhill Hamilton Pty Ltd, a company that provides secretarial and corporate advisory services to a range of listed and unlisted companies. He is also presently the Company Secretary of ASX-listed companies Aeris Environmental Ltd, Vectus Biosystems Limited, Brain Resource Limited and Xref Limited.